InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4G and Corporate Governance Statement 31 Aug 2015 2:07PM $0.036 $0.056 risen by 55.56%
- Appendix 4E and Preliminary Final Report 31 Aug 2015 1:54PM $0.036 $0.056 risen by 55.56%
- Cellmid Launching Major Advertising Campaign 27 Aug 2015 10:15AM $0.035 $0.056 risen by 60%
- Appendix 3Y - Dr Edward Fintan Walton 13 Aug 2015 11:32AM $0.035 $0.056 risen by 60%
- Cellmid appoints EAS to support US Strategy 12 Aug 2015 10:52AM $0.034 $0.056 risen by 64.71%
- Notice of Extraordinary General Meeting/Proxy Form 10 Aug 2015 1:28PM $0.034 $0.056 risen by 64.71%
- CDY Newsletter August 2015 6 Aug 2015 2:37PM $0.036 $0.056 risen by 55.56%
- Cleansing Notice and Appendix 3B 5 Aug 2015 4:55PM $0.040 $0.056 risen by 40%
- Appendix 4C - quarterly 30 Jul 2015 12:15PM $0.036 $0.056 risen by 55.56%
- Cellmid raises $4M to leverage sales growth 30 Jul 2015 8:31AM $0.040 $0.056 risen by 40%
- Trading Halt 28 Jul 2015 9:02AM $0.040 $0.056 risen by 40%
- Appendix 3X - Dr Edward Fintan Walton 23 Jul 2015 4:42PM $0.037 $0.056 risen by 51.35%
- Cellmid Appoints Dr Fintan Walton as Director 21 Jul 2015 9:26AM $0.035 $0.056 risen by 60%
- Letter to Shareholders 15 Jul 2015 3:00PM $0.037 $0.056 risen by 51.35%
- Cellmid Revenue Guidance Upgrade 9 Jul 2015 1:41PM $0.029 $0.056 risen by 93.10%
- Dr Bryce Vissel to Chair Cellmid's Scientific Advisory Board 7 Jul 2015 1:14PM $0.030 $0.056 risen by 86.67%
- Initial Director's Interest Notice - B Gordon 1 Jul 2015 11:01AM $0.030 $0.056 risen by 86.67%
- Final Director's Interest Notice - M Rogers 1 Jul 2015 10:22AM $0.028 $0.056 risen by 100%
- Final Director's Interest Notice - G Kaufman 1 Jul 2015 10:08AM $0.030 $0.056 risen by 86.67%
- Details of Share Registry address 30 Jun 2015 5:07PM $0.030 $0.056 risen by 86.67%
- US Patent for Anti-Midkine Antibodies Granted 29 Jun 2015 10:10AM $0.027 $0.056 risen by 107.41%
- Cellmid Announces Brain Cancer Program 23 Jun 2015 9:13AM $0.025 $0.056 risen by 124%
- Cellmid Invited to Present at Breakfast @ BIO 17 Jun 2015 9:47AM $0.025 $0.056 risen by 124%
- Positive Toxicology Study Results for CAB102 15 Jun 2015 10:33AM $0.023 $0.056 risen by 143.48%
- Cellmid Signs Agreement with Maywufa 2 Jun 2015 11:03AM $0.023 $0.056 risen by 143.48%

401 - 425 of 530 results

Page 17 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.